The Scheduling of Kratom and Selective Use of Data

Kratom is a traditional drug from Southeast Asia that has been an emerging new substance in the United States. On August 30, 2016, the DEA announced the intention to emergency schedule kratom into Schedule I. To support this decision, the DEA cited an increase in drug seizures of kratom and an incre...

Full description

Saved in:
Bibliographic Details
Published inJournal of psychoactive drugs Vol. 50; no. 2; pp. 114 - 120
Main Authors Griffin, O. Hayden, Webb, Megan E.
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.04.2018
Haight Ashbury Publications
Subjects
Controlled Substances Act
Drug Enforcement Administration
drug panic
Federal regulation
Folk medicine
kratom
Psychotropic drugs
Drug Enforcement Administration
kratom
Controlled Substances Act
drug panic
Online AccessGet full text

Cover

Abstract Kratom is a traditional drug from Southeast Asia that has been an emerging new substance in the United States. On August 30, 2016, the DEA announced the intention to emergency schedule kratom into Schedule I. To support this decision, the DEA cited an increase in drug seizures of kratom and an increase in calls to poison control concerning kratom. However, a short time later, on October 12, 2016, the DEA withdrew the intent to schedule kratom after public and congressional backlash. The withdrawal by the DEA was somewhat unprecedented. To better understand both decisions, the current article examines the evidence the DEA cited to support their decision to emergency schedule kratom and the degree and type of media coverage of kratom to determine if a media-driven drug panic occurred.
AbstractList Kratom is a traditional drug from Southeast Asia that has been an emerging new substance in the United States. On August 30, 2016, the DEA announced the intention to emergency schedule kratom into Schedule I. To support this decision, the DEA cited an increase in drug seizures of kratom and an increase in calls to poison control concerning kratom. However, a short time later, on October 12, 2016, the DEA withdrew the intent to schedule kratom after public and congressional backlash. The withdrawal by the DEA was somewhat unprecedented. To better understand both decisions, the current article examines the evidence the DEA cited to support their decision to emergency schedule kratom and the degree and type of media coverage of kratom to determine if a media-driven drug panic occurred.
Author Griffin, O. Hayden
Webb, Megan E.
Author_xml – sequence: 1
  givenname: O. Hayden
  surname: Griffin
  fullname: Griffin, O. Hayden
  email: hgriffin@uab.edu
  organization: Associate Professor, Department of Criminal Justice, University of Alabama at Birmingham
– sequence: 2
  givenname: Megan E.
  surname: Webb
  fullname: Webb, Megan E.
  organization: Doctoral Student, Department of Sociology, University of California, Riverside
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28937941$$D View this record in MEDLINE/PubMed
BookMark eNp9kMlOwzAURS1URAf4BFAk1imeEsc7UBlFJRZt15bjPNNUaVzsBNS_J1Fblqze4p57n3TGaFC7GhC6JnhKcIbvMBWSYEGnFBMxJUwQlrIzNKIkkbEUQgzQqGfiHhqicQgbjHFK0_QCDWkmmZCcjBBdriFamDUUbVXWn5Gz0bvXjdtGui6iBVRgmvIbolWAPnvUjb5E51ZXAa6Od4JWz0_L2Ws8_3h5mz3MY8Mkb-IUJOUszwEYFBw0y7PcmoTbBHeJSTkn0hBtNcEENLDE2syIAicMBKdFzibo9rC78-6rhdCojWt93b1UlGQMc5l08AQlB8p4F4IHq3a-3Gq_VwSr3pQ6mVK9KXU01fVujuttvoXir3VS0wH3B6CsrfNb_eN8VahG7yvnrde1KYNi___4Bc-yd8s
CitedBy_id crossref_primary_10_14309_crj_0000000000000647
crossref_primary_10_1080_15563650_2019_1569236
crossref_primary_10_1080_02791072_2018_1443234
crossref_primary_10_1080_01639625_2022_2158144
crossref_primary_10_1111_bph_14913
crossref_primary_10_1080_02791072_2019_1597224
crossref_primary_10_9740_mhc_2023_06_155
crossref_primary_10_1080_08897077_2021_2007517
crossref_primary_10_5497_wjp_v11_i3_16
crossref_primary_10_1055_a_1826_2766
crossref_primary_10_1016_j_fsisyn_2020_01_019
crossref_primary_10_1080_02791072_2020_1773586
crossref_primary_10_1007_s40265_019_01242_6
crossref_primary_10_1080_01639625_2019_1607114
crossref_primary_10_3390_ijerph17155512
crossref_primary_10_1111_add_15082
crossref_primary_10_1213_ANE_0000000000006177
crossref_primary_10_1016_j_drugpo_2020_102715
crossref_primary_10_1016_j_yebeh_2021_107882
crossref_primary_10_1080_02791072_2021_2006374
crossref_primary_10_3389_fphar_2022_801855
crossref_primary_10_1093_pm_pnab126
crossref_primary_10_3389_fphar_2021_764885
crossref_primary_10_1016_j_fct_2022_113445
crossref_primary_10_3390_toxics10070398
crossref_primary_10_1016_j_etdah_2021_100007
crossref_primary_10_1002_jcph_1923
crossref_primary_10_1016_j_drugpo_2021_103110
crossref_primary_10_7759_cureus_14679
crossref_primary_10_1080_00952990_2020_1836185
Cites_doi 10.1177/1362480612468934
10.1002/dta.v6.9
10.1080/15563650701241795
10.1016/j.forsciint.2014.10.025
10.1093/jat/bku137
10.1080/01639625.2013.766548
10.3109/15563650.2015.1102927
10.1002/jms.1607
10.1155/2015/968786
10.1111/j.1360-0443.2011.03461.x
10.1007/s12103-013-9224-4
10.1016/j.neubiorev.2012.11.012
10.1007/s11419-009-0070-5
10.1080/02791072.1988.10472519
10.1016/j.forsciint.2016.12.020
10.1080/02791072.2015.1096434
10.1016/j.drugalcdep.2014.03.017
10.15585/mmwr.mm6529a4
10.1080/10550490701525368
10.7556/jaoa.2016.156
10.1007/s11418-005-0001-7
10.1016/j.drugalcdep.2004.04.011
10.1080/10282580701677519
10.1016/S0376-8716(00)00191-5
10.1080/10282580701526104
10.1080/02791072.2008.10400629
10.1080/02791072.2016.1229876
10.1111/add.2012.107.issue-4
10.1016/j.drugalcdep.2004.04.012
10.1016/0376-8716(85)90070-5
10.1016/j.jep.2012.03.009
10.1177/0022042612456014
10.1007/s12103-014-9270-6
10.1007/s13181-011-0202-2
10.1016/S0140-6736(07)60464-4
10.1016/j.drugpo.2012.09.004
10.3149/jms.0803.309
10.1007/s13181-010-0079-5
10.1111/dar.12055
10.1056/NEJMp1000695
10.1093/anatox/35.4.242
10.1111/add.2008.103.issue-6
10.2307/3343240
ContentType Journal Article
Copyright 2018 Taylor & Francis Group, LLC 2018
2018 Taylor & Francis Group, LLC
Copyright_xml – notice: 2018 Taylor & Francis Group, LLC 2018
– notice: 2018 Taylor & Francis Group, LLC
DBID NPM
AAYXX
CITATION
K7.
K9.
NAPCQ
DOI 10.1080/02791072.2017.1371363
DatabaseName PubMed
CrossRef
ProQuest Criminal Justice (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
ProQuest Criminal Justice (Alumni)
DatabaseTitleList PubMed
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Social Welfare & Social Work
Psychology
Pharmacy, Therapeutics, & Pharmacology
EISSN 2159-9777
EndPage 120
ExternalDocumentID 10_1080_02791072_2017_1371363
28937941
1371363
Genre Articles
Journal Article
GroupedDBID ---
-DZ
-~X
.7I
.QK
07V
0BK
0R~
29L
36B
4.4
53G
5GY
5RE
6PF
7RV
85S
8R4
8R5
AAGZJ
AAJNR
AALUX
AAMIU
AAPUL
AAQRR
AAWTL
ABBKH
ABDBF
ABEIZ
ABIVO
ABLCE
ABPEM
ABPTK
ABTAI
ABUPF
ACENM
ACGFO
ACGFS
ACGOD
ACHQT
ACLSK
ACNCT
ACTOA
ACVOX
ADCVX
ADFCX
AECIN
AEKEX
AEOZL
AFOLD
AFWLO
AGDLA
AGFJD
AGMYJ
AGRBW
AGYJP
AHMBA
AIJEM
AIRBT
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AMDAE
ARJSQ
AVBZW
BLEHA
BMOTO
BOHLJ
CCCUG
CQ1
DGFLZ
DKSSO
EAP
EAS
EBS
EJD
EMB
EMK
EMOBN
ESX
E~B
E~C
F5P
F8P
FUNRP
G-F
GTTXZ
H13
HF~
HZ~
IPNFZ
J.O
KDLKA
KUULJ
KYCEM
M4Z
NA5
NZ~
O9-
P2P
Q2X
RNANH
RVRKI
RWL
RXW
S-F
STATR
SV3
TAE
TFL
TFW
TN5
TNTFI
TUS
UC6
UEQFS
UT5
UT9
V1K
WH7
YCJ
ZCA
~01
~S~
.GJ
0-V
0VX
3V.
7X7
88E
88I
8AF
8AO
8FI
8FJ
8FW
AAIAR
AAORF
ABFIM
ABJNI
ABLIJ
ABUWG
ABWCV
ABXYU
ABZEW
ACBNA
ACIEZ
ACKZS
ADBBV
ADFOM
ADFZZ
AEIIZ
AFFNX
AFKRA
AFLEI
AJSLH
AJVHN
ALIPV
ALSLI
ALYBC
AMATQ
ARALO
AZQEC
BENPR
BGRYB
BKEYQ
BPHCQ
BRMBE
BVXVI
C04
CCPQU
CYYVM
CZDIS
DMVAR
DRXRE
DWQXO
DWTOO
EX3
FYUFA
G8K
GNUQQ
HCIFZ
HMCUK
H~9
JENTW
LJTGL
M0O
M1P
M2M
M2P
M2Q
NAPCQ
NPM
NUSFT
OHT
PQQKQ
PROAC
PSQYO
PSYQQ
QQXMO
RIG
S0X
TBQAZ
TDBHL
TERGH
TUROJ
UKHRP
WOW
ZCG
ZGI
ZXP
AAYXX
CITATION
K7.
K9.
ID FETCH-LOGICAL-c394t-6e9243bbee3ed4ea3b8bfc54f50e92c64419c1afa101eae35ff8c7d053e742db3
ISSN 0279-1072
IngestDate Wed Nov 06 07:24:09 EST 2024
Fri Dec 06 09:36:38 EST 2024
Wed Oct 16 00:48:15 EDT 2024
Tue Jun 13 19:25:23 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Drug Enforcement Administration
kratom
Controlled Substances Act
drug panic
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c394t-6e9243bbee3ed4ea3b8bfc54f50e92c64419c1afa101eae35ff8c7d053e742db3
PMID 28937941
PQID 2183049505
PQPubID 41415
PageCount 7
ParticipantIDs proquest_journals_2183049505
crossref_primary_10_1080_02791072_2017_1371363
pubmed_primary_28937941
informaworld_taylorfrancis_310_1080_02791072_2017_1371363
PublicationCentury 2000
PublicationDate 2018 Apr-Jun
PublicationDateYYYYMMDD 2018-04-01
PublicationDate_xml – month: 04
  year: 2018
  text: 2018 Apr-Jun
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford
PublicationTitle Journal of psychoactive drugs
PublicationTitleAlternate J Psychoactive Drugs
PublicationYear 2018
Publisher Taylor & Francis
Haight Ashbury Publications
Publisher_xml – name: Taylor & Francis
– name: Haight Ashbury Publications
References CIT0030
CIT0010
CIT0032
CIT0031
CIT0012
CIT0034
Rosenbaum M. (CIT0042) 1991
CIT0011
CIT0033
Bonnie R. J. (CIT0006) 1999
CIT0014
CIT0036
CIT0013
CIT0035
CIT0016
CIT0038
CIT0015
CIT0037
CIT0018
CIT0017
CIT0039
Jenkins P. (CIT0025) 1999
CIT0041
CIT0043
CIT0020
CIT0001
CIT0023
CIT0045
CIT0022
CIT0044
Stogner J. M. (CIT0048) 2013; 32
CIT0003
Reinarman C. (CIT0040) 1997
CIT0047
CIT0002
CIT0024
CIT0046
CIT0005
CIT0027
CIT0049
CIT0004
CIT0026
CIT0007
Himmelstein J. L. (CIT0021) 1983
CIT0029
CIT0028
CIT0009
CIT0008
References_xml – ident: CIT0030
  doi: 10.1177/1362480612468934
– ident: CIT0044
  doi: 10.1002/dta.v6.9
– ident: CIT0004
  doi: 10.1080/15563650701241795
– ident: CIT0026
  doi: 10.1016/j.forsciint.2014.10.025
– ident: CIT0031
  doi: 10.1093/jat/bku137
– ident: CIT0017
  doi: 10.1080/01639625.2013.766548
– ident: CIT0033
  doi: 10.3109/15563650.2015.1102927
– start-page: 18
  year: 1997
  ident: CIT0040
  publication-title: Crack in America: Demon Drugs and Social Justice, ed. C. Reinarman and H. Levine
  contributor:
    fullname: Reinarman C.
– ident: CIT0038
  doi: 10.1002/jms.1607
– ident: CIT0010
  doi: 10.1155/2015/968786
– ident: CIT0009
  doi: 10.1111/j.1360-0443.2011.03461.x
– ident: CIT0015
  doi: 10.1007/s12103-013-9224-4
– ident: CIT0020
  doi: 10.1016/j.neubiorev.2012.11.012
– ident: CIT0027
  doi: 10.1007/s11419-009-0070-5
– volume-title: The marijuana conviction: A history of marijuana prohibition in the United States
  year: 1999
  ident: CIT0006
  contributor:
    fullname: Bonnie R. J.
– volume-title: Synthetic panics: The symbolic politics of designer drugs
  year: 1999
  ident: CIT0025
  contributor:
    fullname: Jenkins P.
– ident: CIT0024
  doi: 10.1080/02791072.1988.10472519
– ident: CIT0013
  doi: 10.1016/j.forsciint.2016.12.020
– ident: CIT0049
  doi: 10.1080/02791072.2015.1096434
– ident: CIT0045
  doi: 10.1016/j.drugalcdep.2014.03.017
– ident: CIT0002
  doi: 10.15585/mmwr.mm6529a4
– ident: CIT0008
  doi: 10.1080/10550490701525368
– ident: CIT0039
  doi: 10.7556/jaoa.2016.156
– ident: CIT0028
  doi: 10.1007/s11418-005-0001-7
– ident: CIT0047
  doi: 10.1016/j.drugalcdep.2004.04.011
– ident: CIT0003
  doi: 10.1080/10282580701677519
– ident: CIT0035
  doi: 10.1016/S0376-8716(00)00191-5
– ident: CIT0046
  doi: 10.1080/10282580701526104
– ident: CIT0018
  doi: 10.1080/02791072.2008.10400629
– ident: CIT0016
  doi: 10.1080/02791072.2016.1229876
– ident: CIT0011
  doi: 10.1111/add.2012.107.issue-4
– ident: CIT0012
  doi: 10.1016/j.drugalcdep.2004.04.012
– ident: CIT0023
  doi: 10.1016/0376-8716(85)90070-5
– ident: CIT0001
  doi: 10.1016/j.jep.2012.03.009
– ident: CIT0014
  doi: 10.1177/0022042612456014
– ident: CIT0032
  doi: 10.1007/s12103-014-9270-6
– ident: CIT0041
  doi: 10.1007/s13181-011-0202-2
– ident: CIT0036
  doi: 10.1016/S0140-6736(07)60464-4
– ident: CIT0043
  doi: 10.1016/j.drugpo.2012.09.004
– ident: CIT0005
  doi: 10.3149/jms.0803.309
– ident: CIT0034
  doi: 10.1007/s13181-010-0079-5
– volume: 32
  start-page: 545
  issue: 5
  year: 2013
  ident: CIT0048
  publication-title: Drug and Alcohol Review
  doi: 10.1111/dar.12055
  contributor:
    fullname: Stogner J. M.
– ident: CIT0022
  doi: 10.1056/NEJMp1000695
– ident: CIT0029
  doi: 10.1093/anatox/35.4.242
– ident: CIT0007
  doi: 10.1111/add.2008.103.issue-6
– volume-title: The strange career of marihuana: Politics and ideology of drug control in the United States
  year: 1983
  ident: CIT0021
  contributor:
    fullname: Himmelstein J. L.
– start-page: 135
  volume-title: The drug legalization debate,ed. J. A. Inciardi
  year: 1991
  ident: CIT0042
  contributor:
    fullname: Rosenbaum M.
– ident: CIT0037
  doi: 10.2307/3343240
SSID ssj0006266
Score 2.3677776
Snippet Kratom is a traditional drug from Southeast Asia that has been an emerging new substance in the United States. On August 30, 2016, the DEA announced the...
SourceID proquest
crossref
pubmed
informaworld
SourceType Aggregation Database
Index Database
Publisher
StartPage 114
SubjectTerms Controlled Substances Act
Drug Enforcement Administration
drug panic
Federal regulation
Folk medicine
kratom
Psychotropic drugs
Title The Scheduling of Kratom and Selective Use of Data
URI https://www.tandfonline.com/doi/abs/10.1080/02791072.2017.1371363
https://www.ncbi.nlm.nih.gov/pubmed/28937941
https://www.proquest.com/docview/2183049505
Volume 50
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLage9kLYuNWKMgPaC8sFY4dJ3nclQo0mLRW7C3ylQdGO3XpQ_n1HF9ymejE2EvU2IlT-Ts5_nzi7xih96rQVtqMJ1rJLHFaxkQIKhJmC2s5V4L6RNpnX_lkxj5fZpfd3nxeXVLLsfq9UVfyEFShDHB1Ktn_QLZtFArgN-ALR0AYjvfG-AJ6Xa-u4uLlL-6redj14sLvcOMWBs1CvP44yNA2cdGgxRLhcr1cdcHzTz6o413Ttw8TsdaddKz5mHNmfoCTOOnHD0jRW3ZivJ-BQb9MgAbmfacYssFG8NOehyNB8_mX541LFdMc-EfuFG4kHxMKU-Dgv3poXP_ycKSOKZWMdANRuzywqXqMtlx-QzZAWweHx4en7RALszDeyLFcovRNT3VpnmM7tzjHrYy0d88rPL-YPkVPIhj4IKC8gx6Z-S7aOw-Zxdf7eNoJ5W728R4-73KOr3fRdjuQwckoaK7xd3NlxdLAxU3BYvnzGUqhKdyZDV5YHMwGg9ng1mwwmI2rc2bzHM1OT6ZHkyRunZEoWrI64Qa6jUppDDWaGUFlIa3KmM0-Qo1yJLhURFgBHtkIQzNrC5Vr8MgmZ6mW9AUazBdz8wphwTXjnqaXkknDhSmlJkIKnabg_MkQjZvOra5DhpSKNIlnIzCVA6aKwAxR2Yegqn1oyoZ9ZCr6j3tHDV5VfBFvKsfyYaILXH6IXgYM23_SmMDrO2veoO3utRihQb1cmbdANGv5LprdH-VhdSM
link.rule.ids 314,780,784,27924,27925
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Scheduling+of+Kratom+and+Selective+Use+of+Data&rft.jtitle=Journal+of+psychoactive+drugs&rft.au=Griffin%2C+O+Hayden&rft.au=Webb%2C+Megan+E&rft.date=2018-04-01&rft.eissn=2159-9777&rft.volume=50&rft.issue=2&rft.spage=114&rft_id=info:doi/10.1080%2F02791072.2017.1371363&rft_id=info%3Apmid%2F28937941&rft.externalDocID=28937941
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0279-1072&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0279-1072&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0279-1072&client=summon